


<rss version="2.0">
<channel>
<title>JCO Highlighted Pediatric Cancers Articles</title><link>http://jco.ascopubs.org/</link><description>American Society of Clinical Oncology (ASCO)</description><image><url>http://www.asco.org/images/ascorss.gif</url><title>JCO Highlighted Pediatric Cancers Articles</title><link>http://jco.ascopubs.org/</link></image><item><title><![CDATA[Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/32/5363]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/32/5343]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/31/5168]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome?Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/31/5175]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/31/5182]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Serum Adiponectin As a Predictor of Childhood Non-Hodgkin's Lymphoma: A Nationwide Case-Control Study]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/30/5049]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric Oncology]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/30/5056]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<it>cis</it>-Retinoic Acid: A Children's Oncology Group Study]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/7/1007]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without <it>MYCN</it> Gene Amplification]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/7/1034]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Iodine-131?Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/7/1020]]></link><description> <![CDATA[]]></description></item>
</channel>
</rss>



